J&J plans to file for an emergency-use authorization in the U.S. next week.
Pfizer Inc. and its German partner plan a first look after just 32 coronavirus infections occurred in their massive 44,000-person trial.
For Americans with these symptoms, there are few answers available on why they surface.
The price ceiling on Pfizer’s product will impact what other companies can charge to protect people from Covid-19.
The U.S. biotech firm’s breakthrough is one of the most promising developments yet.
The technology being used by Moderna relies on the body’s own cells to produce viral proteins.
Early research released in the middle of a health crisis can result in more confusion than clarification.
One path out of the crisis, he says, could be via a massive rollout of in-home testing kits and drive-through sites.
Members of an elite lab of virologists in North Carolina are trying to come up with a drug to treat the pathogen.
The cancer death rate in the U.S. fell by the most on record as advances in treatments.
Please log back in before proceeding.
There was an error logging in. Please try again.
Congrats! You are now logged in. Your exam is being submitted.
